Skip to main content
Fig. 1 | BMC Urology

Fig. 1

From: Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy

Fig. 1

The minimum PSA used to perform the S3 M test by the minimum risk of high-grade prostate cancer as predicted by the S3 M test used to recommend prostate biopsy in order to maintain relative sensitivity compared to when using PSA = 3 ng/ml. Shaded area indicates 95% confidence interval. Data from 3133 men in the STHLM3 study with a S3 M test >10% and a subsequent prostate biopsy

Back to article page